Spots Global Cancer Trial Database for adjuvant therapy
Every month we try and update this database with for adjuvant therapy cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Trastuzumab for 6 Months or 1 Year in Treating Women With Nonmetastatic Breast Cancer That Can Be Removed By Surgery | NCT00381901 | Breast Cancer | trastuzumab polymorphism an... adjuvant therap... | 18 Years - | National Cancer Institute (NCI) | |
| Adjuvant Radiation Therapy Compared With Observation After Surgery in Treating Women With Estrogen Receptor Positive or Progesterone Receptor Positive Ductal Carcinoma In Situ of the Breast Who Are Receiving Tamoxifen or Anastrozole | NCT00077168 | Breast Cancer | anastrozole tamoxifen citra... adjuvant therap... radiation thera... | 40 Years - 70 Years | National Cancer Institute (NCI) | |
| Prolonged Tamoxifen Compared With Shorter Tamoxifen in Treating Patients Who Have Breast Cancer | NCT00003016 | Breast Cancer | tamoxifen citra... adjuvant therap... | - | National Cancer Institute (NCI) | |
| A Phase I Study With a Personalized NeoAntigen Cancer Vaccine in Melanoma | NCT01970358 | Melanoma | Poly-ICLC Peptides | 18 Years - | Dana-Farber Cancer Institute | |
| Combination Chemotherapy in Treating Patients With Stage I, II, or IIIA Non-small Cell Lung Cancer That Has Been Surgically Removed | NCT00003053 | Lung Cancer | cisplatin etoposide adjuvant therap... | - 70 Years | National Cancer Institute (NCI) | |
| Adjuvant Stage 2-3A Breast Cancer With Positive Lymph Nodes | NCT00007904 | Breast Cancer | filgrastim cyclophosphamid... doxorubicin hyd... paclitaxel tamoxifen citra... adjuvant therap... radiation thera... | 18 Years - | Case Comprehensive Cancer Center | |
| Liver Safety Under Upfront Arimidex vs Tamoxifen | NCT00537771 | Breast Cancer | Anastrozole Tamoxifen | - | AstraZeneca | |
| Adjuvant GVAX Vaccine Therapy in Patients With Pancreatic Cancer | NCT00389610 | Pancreatic Canc... | GVAX pancreas v... | 18 Years - | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| Valproic Acid With Temozolomide and Radiation Therapy to Treat Brain Tumors | NCT00302159 | High Grade Glio... Brain Tumors | adjuvant therap... Temozolomide Valproic Acid Radiation thera... | 18 Years - 90 Years | National Institutes of Health Clinical Center (CC) | |
| ABT-888, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme | NCT00770471 | Brain and Centr... | temozolomide veliparib DNA methylation... gene expression... mutation analys... proteomic profi... high performanc... immunoenzyme te... laboratory biom... mass spectromet... pharmacogenomic... pharmacological... adjuvant therap... radiation thera... | 18 Years - 120 Years | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| Radiation Therapy, Temozolomide, and Irinotecan in Treating Patients With Newly Diagnosed Glioblastoma Multiforme | NCT00099125 | Brain and Centr... | irinotecan hydr... temozolomide adjuvant therap... radiation thera... | 18 Years - | Radiation Therapy Oncology Group | |
| The Synergism Or Long Duration (SOLD) Study | NCT00593697 | Breast Neoplasm... | trastuzumab (9 ... trastuzumab (9 ... | 18 Years - | Finnish Breast Cancer Group | |
| Single-arm Study of Nimotuzumab Combined With mFOLFIRNIOX as Postoperative Adjuvant Therapy in Pancreatic Cancer | NCT06389760 | Pancreatic Canc... | Nimotuzumab mFOLFIRINOX | 18 Years - 70 Years | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School | |
| Radiation Therapy With or Without Goserelin in Treating Patients Who Have Undergone Surgery for Recurrent or Refractory Prostate Cancer | NCT00423475 | Prostate Cancer | goserelin aceta... adjuvant therap... radiation thera... | 18 Years - 120 Years | UNICANCER | |
| S0348 Vaccine Therapy in Treating Patients With Stage IIIB or Stage IV Breast Cancer in Remission | NCT00227474 | Breast Cancer | recombinant mod... adjuvant therap... recombinant vir... | 18 Years - | SWOG Cancer Research Network | |
| Tumor Infiltrating Lymphocytes Adjuvant Therapy of Melanoma | NCT00200577 | Melanoma | TIL + IL2 | - 75 Years | Nantes University Hospital | |
| Genotype and Phenotype Guided Supplementation of TAMoxifen Standard Therapy With ENDOXifen in Breast Cancer Patients | NCT03931928 | Breast Cancer DCIS | (Z)-Endoxifen s... (Z)-Endoxifen s... | 18 Years - | Robert Bosch Gesellschaft für Medizinische Forschung mbH | |
| Triptorelin and Radiation Therapy in Treating Patients Who Have Undergone Surgery for Intermediate-Risk Stage III or Stage IV Prostate Cancer | NCT00667069 | Prostate Cancer | triptorelin adjuvant therap... 3-dimensional c... | 18 Years - | UNICANCER | |
| Temozolomide, Thalidomide, and Celecoxib Following Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme | NCT00047294 | Brain and Centr... | celecoxib temozolomide thalidomide adjuvant therap... | 18 Years - 120 Years | Dana-Farber Cancer Institute | |
| Temozolomide, Thalidomide, and Celecoxib Following Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme | NCT00047294 | Brain and Centr... | celecoxib temozolomide thalidomide adjuvant therap... | 18 Years - 120 Years | Dana-Farber Cancer Institute | |
| Trastuzumab for 6 Months or 1 Year in Treating Women With Nonmetastatic Breast Cancer That Can Be Removed By Surgery | NCT00381901 | Breast Cancer | trastuzumab polymorphism an... adjuvant therap... | 18 Years - | National Cancer Institute (NCI) | |
| Combination Chemotherapy Before Surgery in Treating Children With Localized Neuroblastoma | NCT00025428 | Neuroblastoma | carboplatin cyclophosphamid... doxorubicin hyd... etoposide vincristine sul... adjuvant therap... conventional su... neoadjuvant the... | 1 Year - 18 Years | National Cancer Institute (NCI) | |
| Concurrent Adjuvant Carboplatin and Accelerated Radiotherapy for Triple Negative Breast Cancer | NCT01289353 | Breast Cancer | Carboplatin 3D-RT or IMRT | 18 Years - | NYU Langone Health | |
| High-Dose Fluorouracil With or Without Leucovorin Compared With Standard Fluorouracil Plus Leucovorin Following Surgery in Treating Patients With Stage III Colon Cancer | NCT00004150 | Colorectal Canc... | fluorouracil leucovorin calc... adjuvant therap... | 18 Years - | National Cancer Institute (NCI) | |
| Erlotinib in Post Radical Operation NSCLC Patients With EGFR Mutation | NCT01683175 | Non-small Cell ... | Erlotinib cis-platinum Vinorelbine | 18 Years - 75 Years | Tianjin Medical University Cancer Institute and Hospital | |
| Triptorelin and Radiation Therapy in Treating Patients Who Have Undergone Surgery for Intermediate-Risk Stage III or Stage IV Prostate Cancer | NCT00667069 | Prostate Cancer | triptorelin adjuvant therap... 3-dimensional c... | 18 Years - | UNICANCER | |
| PTC Drug Sensitivity Detection to Guide Postoperative Adjuvant of Colorectal Cancer | NCT05978349 | Colo-rectal Can... | adjuvant therap... | 18 Years - 75 Years | Peking Union Medical College Hospital | |
| Observation and/or Combination Chemotherapy After Surgery or Biopsy in Treating Young Patients With Extracranial Germ Cell Tumors | NCT00274950 | Childhood Germ ... Extragonadal Ge... Ovarian Cancer | bleomycin sulfa... carboplatin cisplatin etoposide ifosfamide vinblastine sul... adjuvant therap... conventional su... | - 17 Years | National Cancer Institute (NCI) | |
| Combination Chemotherapy With or Without Cetuximab Before and After Surgery in Treating Patients With Resectable Liver Metastases Caused By Colorectal Cancer | NCT00482222 | Colorectal Canc... Metastatic Canc... | cetuximab capecitabine fluorouracil leucovorin calc... oxaliplatin study of socioe... adjuvant therap... neoadjuvant the... quality-of-life... | 18 Years - | University of Southampton | |
| GM-CSF and Combination Chemotherapy in Treating Patients Who Are Undergoing Surgery for Stage II or Stage III Colon Cancer | NCT00262808 | Colorectal Canc... | sargramostim fluorouracil leucovorin calc... oxaliplatin adjuvant therap... conventional su... neoadjuvant the... | 18 Years - | University of Rochester | |
| Paclitaxel, Carboplatin, and Radiation Therapy With or Without Adjuvant Paclitaxel and Carboplatin in Treating Patients With Stage II or Stage III Unresectable Non-Small Cell Lung Cancer | NCT00077220 | Lung Cancer | carboplatin paclitaxel adjuvant therap... radiation thera... | 18 Years - 79 Years | National Cancer Institute (NCI) | |
| Raltitrexed Concurrent With Radiotherapy for Elderly Chinese Patients With Squamous Cell Carcinoma of Esophagus | NCT03585530 | Esophagus Squam... | raltitrexed | 70 Years - 85 Years | Huai'an First People's Hospital | |
| A Clinical Trial Comparing the Combination of TC Plus Bevacizumab to TC Alone and to TAC for Women With Node-Positive or High-Risk Node-Negative, HER2-Negative Breast Cancer | NCT00887536 | Breast Cancer | bevacizumab docetaxel doxorubicin cyclophosphamid... pegfilgrastim | 18 Years - 70 Years | NSABP Foundation Inc | |
| S-1 and Irinotecan in Treating Patients Who Are Undergoing Surgery for Locally Advanced Stomach Cancer | NCT00134095 | Gastric Cancer | irinotecan hydr... tegafur-gimerac... adjuvant therap... conventional su... neoadjuvant the... | 20 Years - 75 Years | National Cancer Institute (NCI) | |
| Donafenib Combined With TACE as Adjuvant Therapy of Patients With Hepatocellular Carcinoma | NCT05161143 | Hepatocellular ... | Donafenib | 18 Years - 75 Years | Peking Union Medical College Hospital | |
| A Study to Investigate Apatinib Combined Capecitabine on Adjuvant Therapy of Biliary Carcinoma | NCT03609489 | Biliary Carcino... | Capecitabine Apatinib | 18 Years - 75 Years | First Affiliated Hospital of Guangxi Medical University | |
| Erlotinib in Post Radical Operation NSCLC Patients With EGFR Mutation | NCT01683175 | Non-small Cell ... | Erlotinib cis-platinum Vinorelbine | 18 Years - 75 Years | Tianjin Medical University Cancer Institute and Hospital | |
| Immunotoxin Therapy Before and After Surgery in Treating Patients With Recurrent Malignant Glioma | NCT00036972 | Brain and Centr... | cintredekin bes... adjuvant therap... conventional su... neoadjuvant the... | 18 Years - | National Cancer Institute (NCI) | |
| Celecoxib and Erlotinib in Treating Patients With Liver Cancer | NCT00293436 | Liver Cancer | celecoxib erlotinib hydro... adjuvant therap... | 18 Years - | University of California, San Francisco | |
| Chemotherapy Sequential Tislelizumab After Radical Resection in Patients With dMMR/MSI-H or POLE/POLD1 Mutations | NCT06118658 | Gastric Colorectal Aden... | tislelizumab | 18 Years - 75 Years | China Medical University, China | |
| Vaccine Therapy in Treating Patients With Stage II or Stage III Colon Cancer That Has Been Removed During Surgery | NCT00016133 | Colorectal Canc... | BCG vaccine autologous tumo... fluorouracil leucovorin calc... adjuvant therap... | 21 Years - 85 Years | National Cancer Institute (NCI) | |
| Adjuvant Radiation Therapy Compared With Observation After Surgery in Treating Women With Estrogen Receptor Positive or Progesterone Receptor Positive Ductal Carcinoma In Situ of the Breast Who Are Receiving Tamoxifen or Anastrozole | NCT00077168 | Breast Cancer | anastrozole tamoxifen citra... adjuvant therap... radiation thera... | 40 Years - 70 Years | National Cancer Institute (NCI) | |
| Combination Chemotherapy in Treating Patients With Early Stage Breast Cancer That Has Been Removed By Surgery | NCT00301925 | Breast Cancer | pegfilgrastim capecitabine cyclophosphamid... epirubicin hydr... fluorouracil methotrexate adjuvant therap... | 18 Years - 120 Years | Institute of Cancer Research, United Kingdom | |
| Radiation Therapy and Chemotherapy, With or Without Cetuximab, Followed by Surgery in Treating Patients With Locally Advanced Esophageal Cancer That Can Be Removed by Surgery | NCT01107639 | Adenocarcinoma ... Esophageal Canc... | cetuximab cisplatin docetaxel adjuvant therap... neoadjuvant the... | 18 Years - 75 Years | Swiss Group for Clinical Cancer Research | |
| A Phase III PI-88 in the Adjuvant Treatment of Subjects With Hepatitis Virus Related HCC After Surgical Resection | NCT01402908 | Cancer Liver Cancer Hepatocellular ... | PI-88 Placebo | 18 Years - | Cellxpert Biotechnology Corp. | |
| Radiation Therapy Compared With Combination Chemotherapy in Treating Patients With Cancer of the Uterus | NCT00002546 | Sarcoma | cisplatin ifosfamide adjuvant therap... radiation thera... | 21 Years - 120 Years | GOG Foundation | |
| Chemotherapy Before and After Surgery in Treating Children With Wilm's Tumor | NCT00047138 | Kidney Cancer | dactinomycin carboplatin cyclophosphamid... doxorubicin hyd... etoposide vincristine sul... adjuvant therap... conventional su... neoadjuvant the... radiation thera... | - 18 Years | National Cancer Institute (NCI) | |
| Sorafenib as Adjuvant Treatment in the Prevention Of Recurrence of Hepatocellular Carcinoma (STORM) | NCT00692770 | Carcinoma, Hepa... | Nexavar (Sorafe... Placebo | 18 Years - | Bayer | |
| Combination Chemotherapy in Treating Patients Undergoing Surgery for Newly Diagnosed High-Grade Osteosarcoma | NCT00645632 | Sarcoma | cisplatin doxorubicin hyd... ifosfamide methotrexate adjuvant therap... neoadjuvant the... therapeutic con... | - | Mayo Clinic | |
| S9630, Medroxyprogesterone in Treating Women With Breast Cancer | NCT00002920 | Breast Cancer Endometrial Can... | medroxyprogeste... tamoxifen citra... adjuvant therap... | 18 Years - | SWOG Cancer Research Network | |
| Combination Chemotherapy With or Without Surgery & Chemoradiotherapy in Patients With Malignant Pleural Mesothelioma | NCT00354393 | Malignant Mesot... | Cisplatin Methotrexate Vinorelbine dit... Adjuvant therap... Conventional su... Neoadjuvant The... 3-dimensional c... Intensity-modul... | - 75 Years | The Cleveland Clinic | |
| Combination Chemotherapy and Monoclonal Antibody Therapy in Treating Patients With Advanced Colorectal Cancer With Liver Metastases or Lung Metastases That Are Potentially Removable by Surgery | NCT00513266 | Colorectal Canc... Metastatic Canc... | bevacizumab cetuximab fluorouracil irinotecan hydr... leucovorin calc... oxaliplatin laboratory biom... adjuvant therap... biopsy conventional su... neoadjuvant the... | 18 Years - 70 Years | National Cancer Institute (NCI) | |
| Adjuvant Dendritic Cell Immunotherapy for Pediatric Patients With High-grade Glioma or Diffuse Intrinsic Pontine Glioma | NCT04911621 | High Grade Glio... Diffuse Intrins... | Dendritic cell ... Dendritic cell ... | 12 Months - 17 Years | University Hospital, Antwerp | |
| Imatinib Mesylate After a Donor Stem Cell Transplant in Treating Patients With Philadelphia Chromosome-Positive Leukemia | NCT00244829 | Leukemia | imatinib mesyla... adjuvant therap... | - | Fred Hutchinson Cancer Center | |
| High-Dose Radiation Therapy Plus Chemotherapy in Treating Patients With Advanced Nose or Throat Cancer | NCT00052429 | Head and Neck C... | cisplatin fluorouracil adjuvant therap... radiation thera... | 18 Years - 120 Years | Memorial Sloan Kettering Cancer Center | |
| Cetuximab, Leucovorin, Oxaliplatin, and Fluorouracil With or Without Bevacizumab in Treating Patients With Resectable Liver Metastases From Colorectal Cancer | NCT00438737 | Colorectal Canc... Metastatic Canc... | bevacizumab cetuximab fluorouracil leucovorin calc... oxaliplatin adjuvant therap... conventional su... neoadjuvant the... | 18 Years - 80 Years | National Cancer Institute (NCI) | |
| Chemotherapy and Radiation Therapy With or Without Fluorouracil in Treating Patients With Cancer of the Stomach Who Have Undergone Surgery | NCT00011960 | Esophageal Canc... Gastric Cancer | cisplatin paclitaxel adjuvant therap... radiation thera... | - | Radiation Therapy Oncology Group | |
| Adjuvant PD-1 Antibody in Combination With Capecitabine for Patients With ICC at High-Risk of Postoperative Recurrence | NCT04782804 | Cholangiocarcin... | Capecitabine PD-1 Antibody（T... | 18 Years - 75 Years | Fudan University | |
| Carboplatin and Vincristine Plus Radiation Therapy Followed By Adjuvant Chemotherapy in Treating Young Patients With Newly Diagnosed CNS Embryonal Tumors | NCT00003203 | Brain Tumors Central Nervous... Neuroblastoma | filgrastim carboplatin cisplatin cyclophosphamid... vincristine sul... adjuvant therap... radiation thera... | 3 Years - 21 Years | Children's Oncology Group | |
| Prolonged Tamoxifen Compared With Shorter Tamoxifen in Treating Patients Who Have Breast Cancer | NCT00003016 | Breast Cancer | tamoxifen citra... adjuvant therap... | - | National Cancer Institute (NCI) | |
| Radiation Therapy and Combination Chemotherapy in Treating Young Patients With Metastatic Medulloblastoma Who Have Undergone Surgery | NCT00276666 | Brain and Centr... | cisplatin lomustine vincristine sul... adjuvant therap... radiation thera... | 3 Years - 21 Years | National Cancer Institute (NCI) | |
| Combination Chemotherapy and Radiation Therapy in Treating Patients With Germ Cell Tumors in the Brain | NCT00293358 | Brain and Centr... | carboplatin cisplatin etoposide phosp... ifosfamide adjuvant therap... conventional su... neoadjuvant the... radiation thera... | - | National Cancer Institute (NCI) | |
| Ifosfamide and Doxorubicin, Radiation Therapy, and/or Surgery in Treating Young Patients With Localized Soft Tissue Sarcoma | NCT00334854 | Childhood Malig... Sarcoma | doxorubicin hyd... ifosfamide adjuvant therap... conventional su... neoadjuvant the... radiation thera... | - 20 Years | National Cancer Institute (NCI) | |
| Effect of Low Molecular Weight Heparin: Tinzaparin in Lung Tumours (TILT) | NCT00475098 | Lung Cancer Non Small Cell ... | Tinzaparin sodi... | 18 Years - | Assistance Publique - Hôpitaux de Paris | |
| Interleukin-2, Interferon Alfa, and Fluorouracil Compared With Observation in Treating Patients Who Have Undergone Surgery for Kidney Cancer | NCT00053807 | Kidney Cancer | aldesleukin recombinant int... fluorouracil adjuvant therap... | - 75 Years | European Organisation for Research and Treatment of Cancer - EORTC | |
| Celecoxib and Erlotinib in Treating Patients With Liver Cancer | NCT00293436 | Liver Cancer | celecoxib erlotinib hydro... adjuvant therap... | 18 Years - | University of California, San Francisco | |
| A Comparison of Matured Dendritic Cells and Montanide® in Study Subjects With High Risk of Melanoma Recurrence | NCT02334735 | Melanoma | DC Vaccine Montanide Vacci... Poly-ICLC | 18 Years - | Icahn School of Medicine at Mount Sinai | |
| S0307A, Long-Term Bone Quality in Women With Breast Cancer Enrolled on Clinical Trial SWOG-S0307 | NCT00873808 | Breast Cancer | clodronate diso... demeclocycline ... ibandronate sod... tetracycline hy... zoledronic acid laboratory biom... adjuvant therap... computed tomogr... dual x-ray abso... | 18 Years - | SWOG Cancer Research Network | |
| Study of Dose-dense Adriamycin Plus Cytoxan (AC) Followed by Either ABI-007 (Abraxane) or Taxol With Bevacizumab as Adjuvant Therapy for Patients With Breast Cancer | NCT00394251 | Breast Cancer | Adriamycin and ... ABI-007 Taxol Bevacizumab pegfilgrastim | 18 Years - 70 Years | Celgene | |
| Hormone Therapy With or Without Squalamine Lactate in Treating Patients Who Are Undergoing a Radical Prostatectomy for Locally Advanced Prostate Cancer | NCT00244920 | Prostate Cancer | bicalutamide leuprolide acet... squalamine lact... adjuvant therap... antiandrogen th... antiangiogenesi... conventional su... neoadjuvant the... releasing hormo... | 18 Years - | OHSU Knight Cancer Institute | |
| Trastuzumab or Observation After Combination Chemotherapy and Trastuzumab in Treating Patients Undergoing Surgery for Stage II or Stage III Breast Cancer | NCT00533936 | Breast Cancer | trastuzumab cyclophosphamid... doxorubicin hyd... fluorouracil paclitaxel adjuvant therap... conventional su... neoadjuvant the... | 18 Years - 65 Years | National Cancer Institute (NCI) | |
| Leucovorin and Fluorouracil Compared With Observation in Treating Patients With Colorectal Cancer That Has Been Surgically Removed | NCT00005586 | Colorectal Canc... | L-leucovorin fluorouracil adjuvant therap... | 18 Years - | National Cancer Institute (NCI) | |
| Sorafenib, Epirubicin, Ifosfamide, and Radiation Therapy Followed By Surgery in Treating Patients With High-Risk Stage II or Stage III Soft Tissue Sarcoma | NCT00822848 | Sarcoma | epirubicin hydr... ifosfamide sorafenib tosyl... immunoenzyme te... immunohistochem... laboratory biom... adjuvant therap... neoadjuvant the... therapeutic con... hypofractionate... | 15 Years - 120 Years | OHSU Knight Cancer Institute | |
| Pegylated Interferon-alpha-2a in Patients With Malignant Melanoma Stage IIA-IIIB | NCT00204529 | Melanoma | pegylated inter... interferon-alph... | 18 Years - 75 Years | University Hospital Tuebingen | |
| Goserelin in Preventing Early Menopause in Premenopausal Women Undergoing Chemotherapy for Stage I, Stage II, or Stage III Breast Cancer | NCT00427245 | Breast Cancer Infertility Menopausal Symp... | cyclophosphamid... goserelin aceta... adjuvant therap... fertility asses... neoadjuvant the... | - | National Cancer Institute (NCI) | |
| Zoledronic Acid and Combination Chemotherapy in Treating Patients With Newly Diagnosed Metastatic Osteosarcoma | NCT00742924 | Sarcoma | cisplatin dexrazoxane hyd... doxorubicin hyd... etoposide ifosfamide leucovorin calc... methotrexate zoledronic acid adjuvant therap... neoadjuvant the... therapeutic con... filgrastim Mesna | - 40 Years | Children's Oncology Group | |
| Combination Chemotherapy Followed by Radiation Therapy in Treating Patients With Medulloblastoma, Supratentorial Primitive Neuroectodermal Tumor, or Ependymoma | NCT00006258 | Brain and Centr... | filgrastim cisplatin cyclophosphamid... etoposide methotrexate vincristine sul... adjuvant therap... radiation thera... | 10 Years - 65 Years | National Cancer Institute (NCI) | |
| Adjuvant Chemotherapy in Combination With Tislelizumab in Lymph Node-Positive Esophageal Squamous Cell Carcinoma | NCT05984342 | Esophageal Squa... | Tislelizumab | 18 Years - 70 Years | Affiliated Cancer Hospital of Shantou University Medical College | |
| Combination Chemotherapy, Radiation Therapy, and Sargramostim Before and After Surgery in Treating Patients With Soft Tissue Sarcoma That Can Be Removed By Surgery | NCT00652860 | Metastatic Canc... Sarcoma | aerosol sargram... sargramostim cisplatin doxorubicin hyd... ifosfamide mitomycin C flow cytometry immunological d... laboratory biom... adjuvant therap... multimodality t... neoadjuvant the... therapeutic con... intraoperative ... selective exter... | 18 Years - | Mayo Clinic | |
| Partial Breast Radiation Therapy in Treating Women Undergoing Breast Conservation Therapy for Early-Stage Breast Cancer | NCT00599989 | Breast Cancer Long-term Effec... Skin Reactions ... | adjuvant therap... conventional su... 3-dimensional c... brachytherapy intracavitary b... proton beam rad... | 18 Years - 120 Years | Abramson Cancer Center at Penn Medicine |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
